PIERS and BIS, sFIT:PIGF, Adrenomedullin

Launched by SUEZ CANAL UNIVERSITY · Oct 15, 2015

Keywords

ClinConnect Summary

This clinical trial is studying a serious condition called eclampsia, which can occur during pregnancy and is linked to high blood pressure and inflammation. The goal is to better understand how to assess and monitor women who experience eclampsia or are at risk of developing it. By improving the ways we evaluate and care for these patients, researchers hope to reduce health complications for mothers during and after pregnancy.

Women who are currently pregnant and are experiencing eclampsia or have been diagnosed with pre-eclampsia may be eligible to participate in this study. However, those with certain neurological or medical conditions that could affect brain activity will not be included. Participants will undergo specific assessments and monitoring related to their condition. The trial is currently looking for volunteers, and taking part may contribute to important advancements in the care of pregnant women facing these challenges.

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria
• • 1. Pregnancy at any stage (3 trimesters)
• • 2. Eclampsia (Frank eclampsia) will be the crux of the study
• • 3. Pre-eclampsia that is suspected will end up with Frank Eclampsia
• Exclusion criteria:
• • 1. Any neurological conditions that can alter the electroencephalography like epilepsy
• • 2. Any medical conditions that can alter the electroencephalography like hypoglycemia